ISOPTO ATROPINE

This brand name is authorized in Canada, Estonia, United States

Active ingredients

The drug ISOPTO ATROPINE contains one active pharmaceutical ingredient (API):

1 Atropine
UNII 03J5ZE7KA5 - ATROPINE SULFATE

Atropine is an antimuscarinic agent which competitively antagonises acetylcholine at postganglionic nerve endings, thus affecting receptors if the exocrine glands, smooth muscle, cardiac muscle and the central nervous system.

Read about Atropine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ISOPTO ATROPINE Ophthalmic solution FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
S01FA01 Atropine S Sensory organs → S01 Ophthalmologicals → S01F Mydriatics and cycloplegics → S01FA Anticholinergics
Discover more medicines within S01FA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 00035017
Country: EE Ravimiamet Identifier(s): 1138676
Country: US FDA, National Drug Code Identifier(s): 0065-0303

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.